<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-W7WMMLK" height="0" width="0" style="display:none;visibility:hidden"></iframe>
Business

GC Aesthetics® Leads the Way: Insights from the 2023 Gender Equity Index

GC Aesthetics® Leads the Way: Insights from the 2023 Gender Equity Index

Breaking Barriers: GCA® France's 2023 Gender Equity Index Revealed

The Gender Equity Index (GEI) serves as a comprehensive measure that evaluates the state of gender equity across various countries. It primarily assesses disparities between men and women in three key areas: education, economic participation, and empowerment. By comparing these dimensions, the GEI offers insights into the progress and challenges in achieving gender parity, highlighting areas where women may face significant obstacles in accessing equal opportunities and rights. Through its findings, the GEI aims to inform and inspire policy changes and initiatives aimed at closing the gender gap, promoting a more equitable society for individuals of all genders. The purpose of the index is to put an end to gender inequalities in the workplace.

The Gender Equity Index in French companies, as of 2023, provides an illuminating glimpse into the strides and challenges within the landscape of professional equity. GCA® France’s Manufacturing Site score of 98 out of a possible 100 points, the index is a testament to the significant progress being made towards gender equity in the workplace. This comprehensive index is built on four critical indicators that collectively measure the degree of equity between genders. It primarily assesses disparities between men and women in three key areas: education, economic participation, and empowerment. By comparing these dimensions, the GEI offers insights into the progress and challenges in achieving gender parity, highlighting areas where women may face significant obstacles in accessing equal opportunities and rights. 

“For me, the Gender Equality Index is an essential indicator of social progress towards greater equity and justice in the world of work and symbolizes the commitment to a more responsible society. As a company that employs nearly 60% of women, and with an activity that is focused on empowerment and well-being of women, we are particularly sensitive to the fact that our HR actions contribute to the promotion of equal treatment within our company.” - Elise NOCLAIN, GCA France HR Manager 

The first indicator focuses on the pay gap between women and men, where a score of 38 out of 40 has been achieved. This reflects a narrowing gap, signifying that women are increasingly receiving compensation commensurate with their male counterparts for similar roles and responsibilities. This progress is crucial, as it not only fosters a sense of fairness but also enhances women's financial independence and security.

The second indicator assesses the distribution of individual increases, awarding a perfect score of 35 out of 35. This suggests an equitable recognition of performance and merit across genders, indicating that advancements and pay raises are distributed without bias. Such a practice ensures that employees are motivated and rewarded fairly, which can lead to a more productive and engaged workforce.

Another vital component of the index is the evaluation of the number of employees who receive an increase after maternity leave, for which the score is an impressive 15 out of 15. This indicator is particularly noteworthy as it underscores the commitment of companies to support and value the contributions of women, even as they balance their professional and personal lives. It signals to employees that taking maternity leave will not adversely affect their career progression or financial remuneration, thereby encouraging a more inclusive and supportive workplace culture.

Lastly, the index evaluates parity among the highest compensation packages within organizations, GCA® France scored 10 out of 10.  Achieving full marks in this indicator illustrates that women are not only present in high-ranking positions but are also being compensated on an equal footing with their male counterparts. This is a significant indicator of gender equity, as it reflects both access to top-tier positions and fair compensation practices at the highest levels of organizational hierarchy.

In summary, the 2023 Gender Equity Index for GCA ® France paints a promising picture of the ongoing efforts to bridge the gender gap in professional settings. With an overall score of 98 out of 100, there is still room for improvement. However, the scores across all four indicators demonstrate a strong commitment to fostering a workplace where gender does not determine one's opportunities, compensation, or professional growth. These findings not only highlight the progress made but also underscore the importance of continuous efforts to achieve full gender equity in the professional realm.

GC Aesthetics®, A Confident Choice for Life™

Read more
GC Aesthetics® is delighted to participate as a Platinum sponsor at the Barcelona Breast Meeting 2024
Read more
GCA® is proud to be the main sponsor of the 12th International Breast Symposium

Recommended For You

Business
GC Aesthetics® Announces Decade-Long Clinical Evaluation of PERLE™ Breast Implants
Read more
Business
GC Aesthetics® Announces Decade-Long Clinical Evaluation of PERLE™ Breast Implants
Read more
Business
GC Aesthetics® Announces Decade-Long Clinical Evaluation of PERLE™ Breast Implants
Read more

Disclaimer

The information presented here is not intended or implied to be a substitute for professional medical advice, diagnosis, or treatment. All content and information contained on or available through this website is for general information purposes only. GC Aesthetics® makes no representation and assumes no responsibility for the accuracy of the information contained here, and such information is subject to change without notice. You are encouraged to confirm any information obtained from or through this content with other sources and review all information regarding any medical condition or treatment with your physician.